- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-22-0035028

Cognatio Pharmaceuticals Private Limited
About Cognatio Pharmaceuticals Private Limited
Data last updated:
Cognatio Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 25 August 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2022PTC389267.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramegowda Marur Manje Gowda (Managing Director) and Chaithra Ramegowda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.15 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹59,390 (net margin 1.4%) and EBITDA of ₹84,925 (EBITDA margin 2%).
Cognatio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0035028). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Cognatio Pharmaceuticals
Contact details
Cognatio Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressRoom No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cognatio Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Cognatio Pharmaceuticals Private Limited, buy the company report.
Financials of Cognatio Pharmaceuticals Private Limited
FY 2025 filings availableCognatio Pharmaceuticals Private Limited reported revenue of ₹43.15 Lakh (up 908% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 908% in the latest year. EBITDA rose 93% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹84,925 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹59,390 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2% | |
| Net Profit Margin | 1.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cognatio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cognatio Pharmaceuticals Private Limited
Cognatio Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramegowda Marur Manje Gowda | Managing Director | 25 Aug 2022 | 4 Years 2 Months | Current |
| Chaithra Ramegowda | Director | 25 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Cognatio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cognatio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cognatio Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cognatio Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Chaithra Ramegowda was appointed as Director on 25 Aug 2022.
Frequently asked questions
Cognatio Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 25 August 2022 (4+ years old) and is registered under CIN U74999MH2022PTC389267.
Cognatio Pharmaceuticals has 2 current directors:
- Ramegowda Marur Manje Gowda - Managing Director
- Chaithra Ramegowda - Director
The latest financial statements of Cognatio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Cognatio Pharmaceuticals is U74999MH2022PTC389267. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cognatio Pharmaceuticals was incorporated on 25 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Chaithra Ramegowda was appointed as Director on 25 Aug 2022. Ramegowda Marur Manje Gowda was appointed as Managing Director on 25 Aug 2022.
Yes, Cognatio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0035028).
The registered office of Cognatio Pharmaceuticals is at Room No 2 Laxmi Store Annaya Chawl Opp. Bmc School Laxmi Nagar Dhrkhadi Dahisar East, Mumbai, Maharashtra, India – 400068.
Cognatio Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Cognatio Pharmaceuticals is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.

